• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Related Links
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of High Institute of Public Health
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 54 (2024)
Volume Volume 53 (2023)
Volume Volume 52 (2022)
Volume Volume 51 (2021)
Volume Volume 50 (2020)
Volume Volume 49 (2019)
Volume Volume 48 (2018)
Volume Volume 47 (2017)
Volume Volume 46 (2016)
Volume Volume 45 (2015)
Volume Volume 44 (2014)
Volume Volume 43 (2013)
Volume Volume 42 (2012)
Volume Volume 41 (2011)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 40 (2010)
Volume Volume 39 (2009)
Volume Volume 38 (2008)
Volume Volume 37 (2007)
Volume Volume 36 (2006)
Volume Volume 35 (2005)
Volume Volume 34 (2004)
Volume Volume 33 (2003)
Volume Volume 32 (2002)
Volume Volume 31 (2001)
Volume Volume 30 (2000)
Volume Volume 29 (1999)
Zaher, E., Saad, A., Al-Naggar, M. (2011). Correlation of Ghrelin, Adiponectin and Leptin to BMI and Treatment Outcome in Breast Cancer Patients. Journal of High Institute of Public Health, 41(3), 325-340. doi: 10.21608/jhiph.2011.20163
Ebtsam Zaher; Ahmed Saad; Mostafa Al-Naggar. "Correlation of Ghrelin, Adiponectin and Leptin to BMI and Treatment Outcome in Breast Cancer Patients". Journal of High Institute of Public Health, 41, 3, 2011, 325-340. doi: 10.21608/jhiph.2011.20163
Zaher, E., Saad, A., Al-Naggar, M. (2011). 'Correlation of Ghrelin, Adiponectin and Leptin to BMI and Treatment Outcome in Breast Cancer Patients', Journal of High Institute of Public Health, 41(3), pp. 325-340. doi: 10.21608/jhiph.2011.20163
Zaher, E., Saad, A., Al-Naggar, M. Correlation of Ghrelin, Adiponectin and Leptin to BMI and Treatment Outcome in Breast Cancer Patients. Journal of High Institute of Public Health, 2011; 41(3): 325-340. doi: 10.21608/jhiph.2011.20163

Correlation of Ghrelin, Adiponectin and Leptin to BMI and Treatment Outcome in Breast Cancer Patients

Article 2, Volume 41, Issue 3, July 2011, Page 325-340  XML PDF (295.3 K)
Document Type: Original Article
DOI: 10.21608/jhiph.2011.20163
View on SCiNiTO View on SCiNiTO
Authors
Ebtsam Zaher* 1; Ahmed Saad2; Mostafa Al-Naggar3
1Department of Radiation Sciences, Medical Research Institute, Alexandria University, Alexandria, Egypt
2Department of Experimental and Clinical Surgery, Medical Research Institute, Alexandria University, Alexandria, Egypt
3Cancer Management and Research Departments, Medical Research Institute, Alexandria University, Alexandria, Egypt
Abstract
Background: Body mass index (BMI) is an independent prognostic factor for survival in breast cancer patients. Patients with higher BMI were found to have poorer cancer prognosis and lower survival rates. Many factors as ghrelin, adiponectin and leptin, have been implicated in obesity but their correlation with breast carcinogenesis and treatment outcome is still a debate. Objective: Toidentify the relation of ghrelin, adiponectin and leptin with BMI in breast cancer patients and their possible role in carcinogenesis and treatment outcome. Methods: Sera from 80 breast cancer patients were analyzed. Ghrelin, adiponectin and leptin were assayed by commercial RIA kits, and their levels were correlated with BMI, clinicopathological parameters and relapse-free survival. The median duration of patients' follow-up was 32 months. Results: 73.7% of the cohort was overweight/ obese. Compared to breast cancer patients with normal BMI, overweight/obese patients had a significantly higher tumor size and higher histological grade. Overweight/obese patients had higher leptin and lower ghrelin and adiponectin levels. Adiponectin was lower in patients with higher tumor grade and lymph node involvement, while ghrelin decreased with increasing tumor size and histological grade. Only serum ghrelin levels were significantly correlated to better disease-free survival. Conclusion: Ghrelin, adiponectin and leptin are significant factors in controlling BMI in breast cancer patients but only ghrelin is a significant predictor of better outcome and recurrence-free survival.
Keywords
adiponectin; Body mass index (BMI); breast cancer; ghrelin; leptin; Survival
Statistics
Article View: 172
PDF Download: 444
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.